First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease

Retrieved on: 2024-11-19 20:43:13

Tags for this article:

Autoimmune diseases

Connective tissue diseases

Syndromes

Chemical pathology

Cutaneous lupus erythematosus

Anti-SSA/Ro autoantibodies

Adicet Bio Inc.

Click the tags to see associated articles and topics

First Patient Dosed in Trial for Adicet's T-Cell Therapy ADI-100 in Autoimmune Disease. View article details on hiswai:

Excerpt

Adicet additionally noted that it plans to announce initial data from patients with LN in the first half of 2025. View next. Atamyo Therapeutics' Gene ...

Article found on: www.cgtlive.com

View Original Article